Celltrion Healthcare Launches IBD Awareness Campaign in Collaboration With Leading Patient Organisation, EFCCA, for World IBD Day 2023
Celltrion Healthcare has partnered with a leading patient organisation, the European Federation of Crohn’s & Ulcerative Colitis Associations (EFCCA), to raise awareness of inflammatory bowel disease (IBD) this World IBD Day (19 May 2023).
The campaign, Where’s CC?(Crohn’s and Colitis), aims to spark conversations about the impact of IBD across people’s lives and how these challenges vary between different age groups.
People are being encouraged to find the hidden CC characters and learn more about the unique challenges they have faced from being diagnosed with IBD to finding a treatment that works for them, at different stages of life, based on real-life patient insights.
Over ten million people worldwide are living with IBD1, a group of conditions including Crohn’s disease and ulcerative colitis (UC). IBD is most commonly diagnosed between the ages of 10 and 401, however it can appear at any point during people’s lives, with 10% to 15% of newly diagnosed cases of IBD being over the age of 60.2
Clinical research, education and understanding however do not reflect this, leaving groups of people feeling left behind and underrepresented. This can impact patient’s ability to benefit from innovative treatment options and high-quality care, impacting their quality of life and disease outcomes.
Visit www.WhereisCC.com to learn more about the campaign and help in shining a light on IBD by finding CC and learning more about their unique experiences.
Kevin Byoung Seo Choi, Senior Vice President and Head of Marketing Division at Celltrion Healthcare, said: “Every IBD patient, no matter their age, deserves to feel understood and have access to high quality care and effective, innovative treatments. Innovations in treatments, including advances in treatment administration that enable people to access at-home injectable treatment allows people to have an improved quality of life whilst managing their condition. We are extremely proud to launch the Where’s CC? campaign in collaboration with EFCCA for World IBD Day 2023 to improve understanding of IBD and the challenges that are associated with specific stages of life.
“Through our partnership with EFCCA, we have unparalleled opportunity to turn the tide in IBD and ensure no patient feels alone or left behind in their unique journey.”
Salvo Leone, EFCCA Chairman, commented: “IBD has no age, yet people living with IBD are facing challenges associated with their age that prevent them benefitting from the best treatment options.
“This World IBD Day, we are delighted to have partnered with Celltrion Healthcare to spotlight some of these challenges to raise awareness and improve care for IBD patients across the world. The Where’s CC? campaign includes important patient resources, and we encourage everyone to spread the word as we work towards a situation where all IBD patients can have a good quality of life.”
Molly O’Donoghue, UC patient, said: “Being diagnosed with UC at 15, I thought I would never be able to move away to university or go travelling with my friends. I was on a downward spiral, becoming depressed and isolated, until I found an at-home treatment that gave me a new freedom to do these things as I had always wanted.
“It is so important that people with IBD are not ashamed of their condition, and we talk about the challenges that come with learning to live with the condition at different stages of life. The Where’s CC? campaign is a brilliant way to raise awareness and help people to overcome the challenges that IBD brings.”
- ENDS -
Notes to Editors:
About Inflammatory Bowel Disease (IBD)
IBD is an umbrella term used to describe conditions including Crohn’s disease and UC. Collectively, IBD impacts over ten million people worldwide.1
IBD is a long-term condition and there may be times when the symptoms are severe, known as a flare-up, and times where there are no or few symptoms, known as remission. Symptoms can be debilitating if the condition is not well managed. These often include abdominal pain and cramping, diarrhoea, weight loss and extreme tiredness.3
Treatment for IBD can be transformative in patients’ lives, reducing the impact of the condition on their lives by minimising flare-up of symptoms and maintaining remission. In recent years, the increasing availability of new treatments has transformed IBD patient care. Innovations in treatments, including advances in treatment administration that enable people to access at-home injectable treatment (versus hospital-based treatment), allows people to have an improved quality of life whilst managing their condition.
About Celltrion Healthcare
Celltrion Healthcare is committed to delivering innovative and affordable medications to promote patients’ access to advanced therapies. Its products are manufactured at state-of-the-art mammalian cell culture facilities, designed and built to comply with the US FDA Current Good Manufacturing Practice (cGMP) and the EU GMP guidelines. Celltrion Healthcare endeavours to offer high-quality cost-effective solutions through an extensive global network that spans more than 110 different countries. For more information, please visit: https://www.celltrionhealthcare.com
The European Federation of Crohn's & Ulcerative Colitis Associations (EFCCA) represents 46 national Crohn’s and ulcerative colitis (collectively known as Inflammatory Bowel Disease or IBD) patient associations. We are an organization of people united in our commitment to improve the life of over 10 million people living with IBD worldwide (3.4 million in Europe alone) and to give them a louder voice and more visibility. For more information, please visit: https://efcca.org/
1 EFCCA. What is IBD? Available at: https://efcca.org/content/what-ibd [Accessed May 2023]
2 EFCCA. World IBD Day 2023. Available at: https://efcca.org/projects/world-ibd-day-2023 [Accessed May 2023]
3 NHS. Inflammatory bowel disease. Available at: https://www.nhs.uk/conditions/inflammatory-bowel-disease/ [Accessed May 2023]
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HCLTech Expands Footprint in Romania With New Global Delivery Center in Iași8.12.2023 15:56:00 CET | Press release
HCLTech, a leading global technology company, announced the launch of its new Global Delivery Center (GDC) in Iași, Romania. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231208755841/en/ Mayor of Iași, Mihai Chirica, cuts the inaugural ribbon of HCLTech’s new delivery center with the company’s CEO and MD, C Vijayakumar; its Romania country leader, Iulian Paduraru; and SVP, Shiv Walia. (Photo: Business Wire) The new state-of-the art center in Iași will provide next-generation digital, engineering, cloud and AI solutions. The center expands HCLTech’s presence in Romania and underscores its commitment to the country as part of its nearshore strategy to serve global clients. “This is a significant milestone for HCLTech in Romania as we continue our growth journey and serve our global clients with new capabilities in the latest technologies. We remain committed to our people and local communities and will continue investing in
Michelob Ultra Partners With Lionel Messi to Announce Being Named the Official Global Beer Sponsor of CONMEBOL Copa América USA 2024™8.12.2023 15:00:00 CET | Press release
AB InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD), the world’s leading brewer, and CONMEBOL (Confederación Sudamericana de Fútbol), the governing body of South American football, will elevate their partnership with Michelob Ultra as the Official Global Beer Sponsor of Copa América USA 2024™. This renewed agreement deepens the company’s longstanding commitment to fans around the globe through the world’s most popular sporting events. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231208607579/en/ Michelob Ultra partners with Lionel Messi to announce being named the Official Global Beer Sponsor of CONMEBOL Copa América USA 2024™ (Photo: Business Wire) Michelob Ultra is proud to also announce that CONMEBOL Copa América champion and global football icon, Lionel Messi, will be a new brand ambassador. He shared his excitement for the news: “I am so proud to join Michelob Ultra for its activations at CONMEBOL Copa América USA 2
COP28 Presidency Recognises ReNew as Clean Energy Transition Changemaker8.12.2023 14:50:00 CET | Press release
ReNew Energy Global Plc ("ReNew") (Nasdaq: RNW, RNWWW), India’s leading renewable energy company, has been named a Clean Energy Transition Changemaker by the COP28 Presidency for its work on the Round-the-Clock Power Project. Energy Transition Changemakers is a new COP28 UAE Presidency initiative which aims to foster private sector collaboration in delivering innovative and scalable decarbonization projects globally and demonstrate solutions to help enable and accelerate the energy transition. Sumant Sinha, Founder, Chairman and CEO, ReNew, said: “This recognition is testament to ReNew’s leadership and innovation in the renewable energy sector and our role as a leading decarbonisation partner." The ~1.3 GW Round-the-Clock Power Project is a first-of-its-kind project in India that is helping accelerate the just energy transition and ReNew is the only Indian company to be featured by the COP 28 Presidency as part of the Changemaker honours. ReNew’s wind and solar projects are already sup
Wilshire Completes Acquisition of Lyxor U.S.8.12.2023 14:00:00 CET | Press release
Wilshire, a leading global financial services firm, today announced the completion of its previously announced acquisition of Lyxor Asset Management Inc. (“Lyxor U.S.”), the U.S.-based investment advisor business of Lyxor Asset Management with $20.8 billion in assets under management1. This transaction brings together two firms that share an unwavering commitment to improving investment outcomes for clients. With the addition of Lyxor U.S., Wilshire is able to offer an enhanced suite of investment products and a leading alternatives platform to support a broader range of investment opportunities for clients of both legacy businesses. Financial terms of the transaction were not disclosed. About Wilshire Wilshire is a leading global financial services firm and trusted partner to a diverse range of more than 500 leading institutional investors and financial intermediaries. Our clients rely on us to improve investment outcomes for a better future. Wilshire advises on over $1.3 trillion in
Klas announces Kortex™ V, a mobile command post for decentralized decision making8.12.2023 13:00:00 CET | Press release
Klas, a global leader in edge technology, announces the availability of Kortex V, a scalable mobile command post for decentralized decision making. Kortex V is designed to support compute intensive applications of command, control and communications (C3) and private multi-clouds in austere and degraded, denied, intermittent and limited (DDIL) connectivity environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231206630884/en/ Kortex™ V, from Klas, the ultimate in highly-mobile command post technology. Kortex V decentralizes C3 capabilities and disperses them in a rugged, modular, battery-backed, TrueTactical™ form factor for resiliency. High-performance compute is located where data adds value, supporting more efficient operations where connectivity is challenging. (Photo: Business Wire) Kortex V is the first commercially available compute platform to support the modernization of the command post by eliminating the cen